SCHEMBL14280887

SCHEMBL14280887

COc1ccc(C(=O)/C=C/c2cc(-c3ccccc3OC)ccc2N2CCN(C)CC2)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
HPGD P15428 3/20 0.48
ALDH1A1 P00352 3/20 0.48
GAA P10253 2/20 0.48
ALOX12 P18054 1/20 0.48
CPS1 P31327 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
TNFRSF1A P19438 1/20 0.43
NPY2R P49146 1/20 0.43
MAPT P10636 4/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694917 1.00 LMNA (0.48) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3693494 0.97 LMNA (0.45) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3688311 0.94 CPS1 (0.44) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3686384 0.92 CPS1 (0.43) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3688283 0.92 ABCG2 (0.45) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3688916 0.91 MEN1 (0.46) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3694916 0.91 TUBB4A (0.45) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3686603 0.91 NR1H4 (0.47) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3695263 0.91 TUBB4A (0.45) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL3687219 0.91 MEN1 (0.44) LMNAMEN1KMT2AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027075-A1 Quaternary Amino-Function Chalcones LICA PHARMACEUTICALS A/S (DK) 2008-01-31 US disclosed
US-20080027075-A1 Quaternary Amino-Function Chalcones LICA PHARMACEUTICALS A/S (DK) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027075-A1 Quaternary Amino-Function Chalcones NR2E1, BET1, NR0B1 LMNA 3987/4885MEN1 3513/4885KMT2A 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.